Xiangyu Medical(688626)2025-01-22 09:10Revenue Projections - The company expects 2024 annual revenue to be between 730 million and 750 million CNY, representing a year-over-year change of a decrease of 14.81 million to an increase of 5.19 million CNY, or a decline of 1.99% to an increase of 0.70%[3]. - The previous year's revenue was 744.81 million CNY[5]. Profit Projections - The projected net profit attributable to the parent company for 2024 is expected to be between 950 million and 1.1 billion CNY, a decrease of 117.14 million to 132.14 million CNY compared to the previous year, reflecting a decline of 51.57% to 58.18%[3]. - The expected net profit attributable to the parent company after deducting non-recurring gains and losses is projected to be between 820 million and 950 million CNY, a decrease of 109.04 million to 122.04 million CNY year-over-year, indicating a decline of 53.44% to 59.81%[3]. - The previous year's net profit attributable to the parent company was 227.14 million CNY[6]. - The previous year's net profit attributable to the parent company after deducting non-recurring gains and losses was 204.04 million CNY[7]. Challenges and Strategies - The company emphasizes continuous technological innovation and management improvement despite facing challenges, leading to stable revenue[8]. - Increased hiring of high-end rehabilitation technology talent and rising R&D costs contributed to the decline in net profit[8]. Financial Data and Risks - The financial data in the performance forecast has not been audited by a registered accountant[4]. - Investors are advised to pay attention to investment risks as the forecast data is preliminary and subject to change upon the release of the audited annual report[11].